โ† All Topics / ade

FDA ADE reports for Bexagliflozin

ade_bexagliflozin_adverse_events

ade en 2026-07-22

Bexagliflozin โ€” FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Bexagliflozin is a active ingredient.

Total reports

Bexagliflozin: 3835

Reports by species (top entries)

  • Cat 3770
  • Dog 18
  • Fallow 1
  • Other 1

Top reported reactions (VEDDRA terms, top entries)

  • Ketosis 1470
  • Weight loss 1018
  • Hyperglycaemia 848
  • Diarrhoea 722
  • Lack of efficacy - NOS 551
  • Vomiting 429
  • Lethargy (see also Central nervous system depression in Neurological) 421
  • Hypoglycaemia 403
  • Other abnormal test result NOS 389
  • Glucosuria 355

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b9.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).